What is the general follow-up recommendation for patients with Lobular Carcinoma In Situ (LCIS) who choose not to undergo surgical resection?

Patients with Lobular Carcinoma In Situ (LCIS) who opt not to pursue surgical resection typically require a careful surveillance strategy due to the elevated risk of developing invasive breast cancer. Regular mammography is a cornerstone of this surveillance approach, as it helps in early detection of any potential malignant developments.

The recommendation for regular mammography is based on evidence that while LCIS itself is not a direct precursor to cancer, it signifies an increased risk of subsequent breast cancer, making monitoring essential. The timing and frequency of mammograms may vary depending on individual risk factors and the recommendations of their healthcare provider, but the general practice is to conduct these evaluations annually.

In addition to mammography, careful follow-up involves clinical evaluations and potential discussions about additional imaging or interventions that may be appropriate based on individual risk assessment. This approach underlines the importance of logistic and preventive measures rather than immediate invasive treatments, such as chemotherapy, which is not indicated in asymptomatic patients with LCIS who aren't undergoing surgical intervention.

Thus, the recommendation aligns with a proactive monitoring strategy that balances the need for vigilance against breast cancer risk with the acknowledgment of LCIS as a non-invasive lesion.